Evidence map›Paper›PMID 39526877›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025

Gastric Cancer Risk among Immigrants and Socioeconomic Groups in the Netherlands.

Duco T Mülder, Hilliene J van de Schootbrugge-Vandermeer, James F O'Mahony, Dianqin Sun, Weiran Han, Rob H A Verhoeven, Marlon van Loo, Wessel van de Veerdonk, Manon C W Spaander, Iris Lansdorp-Vogelaar

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. A systematic review of factors associated with the patient and diagnostic intervals in gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Duco T MülderDepartment of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.ORCID 0000-0001-7226-322X
Hilliene J van de Schootbrugge-VandermeerDepartment of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.ORCID 0000-0002-0543-4225
James F O'MahonyDepartment of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.ORCID 0000-0003-3414-7388
Dianqin SunDepartment of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.ORCID 0000-0003-1184-9758
Weiran HanDepartment of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.ORCID 0009-0000-9847-7816
Rob H A VerhoevenDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.ORCID 0000-0001-9678-1611
Marlon van LooPeople and Well-Being Research Group, Centre of Expertise Care and Well-Being, Thomas More University of Applied Sciences, Antwerp, Belgium.ORCID 0000-0002-4055-8231
Wessel van de VeerdonkPeople and Well-Being Research Group, Centre of Expertise Care and Well-Being, Thomas More University of Applied Sciences, Antwerp, Belgium.ORCID 0000-0002-3074-7493
Manon C W SpaanderDepartment of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.ORCID 0000-0002-9103-9757
Iris Lansdorp-VogelaarDepartment of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.ORCID 0000-0002-9438-2753

Funding

European Union 101101252
6 · The paper itself

Abstract

backgroundIdentification of groups at a high risk of gastric cancer could facilitate targeted screening in countries with a low gastric cancer incidence. Our aim was to identify such high-risk groups based on individual-level population data on migration history and socioeconomic status (SES) in the Netherlands.

methodsIn this retrospective cohort study, patient data from the Netherlands Cancer Registry were linked to demographic data of Statistics Netherlands in the period 2010 to 2022. Gastric cancer incidence rates in the 14 largest immigrant populations were compared with those born in the Netherlands. Odds ratios (OR) were computed per birthplace and controlled for age, sex, and SES. Additionally, we investigated gastric cancer risk among second-generation immigrants and by SES.

resultsImmigrant populations at a significantly higher gastric cancer risk compared with the general population were identified. Specifically, foreign-born first-generation immigrants from Bosnia-Herzegovina (OR, 2.42), Turkey (OR, 2.22), and China (OR, 1.92) showed elevated risk. Whereas low SES increased the odds of developing gastric cancer, first-generation immigrants remained at higher risk even after controlling for SES. Second-generation immigrants did not have a significantly higher risk of developing gastric cancer.

conclusionsCertain first-generation immigrants remain at an elevated risk for gastric cancer despite migration to a low-risk region. Identification of these high-risk groups should be used to facilitate targeted gastric cancer prevention. IMPACT: Potential benefits of targeted Helicobacter pylori test-and-treat policy in immigrant populations should be explored in clinical and modeling studies. Primary care physicians should be cognizant of high-risk groups, facilitating the early detection of cancer within these populations.

Indexed as

Emigrants and ImmigrantsStomach NeoplasmsAdultAgedFemaleHumansIncidenceMaleMiddle AgedNetherlandsRegistriesRetrospective StudiesRisk FactorsSocial ClassSocioeconomic Factors

Identifiers

PMID39526877
PMCPMC11712039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.